InvestorsHub Logo
Followers 61
Posts 7514
Boards Moderated 2
Alias Born 02/10/2010

Re: found_it post# 95522

Monday, 07/28/2014 10:58:53 AM

Monday, July 28, 2014 10:58:53 AM

Post# of 146194
I think (personally) that it may be rapidly approaching a time where more unconventional measures are employed. If they cannot contain this outbreak reasonably soon - it's going to get to more populated areas where it can cause huge, and spreading problems.

The biggest epidimological factor that has kept Ebola/Marbug limited in spread has been the fact that it is so HOT that it tends to self-limit - especially since to this point it is only spread by contact and has not been demonstrated to be airborne.

In a crowded city, with poor sanitation, and lots of potential people to get infected - this limitation starts to get discounted.

But the key problem from an NNVC standpoint is pointed out by Dr. Farrar in the second segment of what you post is as follows:

"Any new intervention must have preclinical safety and efficacy data and Phase I safety data in healthy volunteers,"



We don't have that - even from Flucide at this point - let alone from an Ebolacide formulation. Things will have to get really, really, really bad before something as experimental as an NNVC Ebolacide gets deployed prior to at least finishing Phase I testing.

Let's all hope that things don't get so bad that an NNVC Ebolacide gets deployed.

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News